Page last updated: 2024-08-25

bendamustine hydrochloride and B-Cell Leukemia

bendamustine hydrochloride has been researched along with B-Cell Leukemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, JR; Danilov, AV; Gordon, MJ; Lewis, LD1
Awan, FT; Costa, LJ; Gao, L; Gore, L; Lager, J; Sharma, J1
Albiero, E; Bernardi, M; Castegnaro, S; Chieregato, K; Madeo, D; Rodeghiero, F; Visco, C; Zanon, C1

Reviews

1 review(s) available for bendamustine hydrochloride and B-Cell Leukemia

ArticleYear
Bendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose?
    Expert review of hematology, 2017, Volume: 10, Issue:8

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials as Topic; Comorbidity; Humans; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Treatment Outcome

2017

Trials

1 trial(s) available for bendamustine hydrochloride and B-Cell Leukemia

ArticleYear
Phase Ib trial of the PI3K/mTOR inhibitor voxtalisib (SAR245409) in combination with chemoimmunotherapy in patients with relapsed or refractory B-cell malignancies.
    British journal of haematology, 2016, Volume: 175, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Drug Administration Schedule; Drug Monitoring; Drug Resistance, Neoplasm; Female; Humans; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Maximum Tolerated Dose; Middle Aged; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Recurrence; Retreatment; Rituximab; Sulfonamides; TOR Serine-Threonine Kinases; Treatment Outcome

2016

Other Studies

1 other study(ies) available for bendamustine hydrochloride and B-Cell Leukemia

ArticleYear
Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:11

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cytarabine; Humans; Leukemia; Leukemia, B-Cell; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Nitrogen Mustard Compounds

2012